Using Advanced Techniques for Protein Bioanalysis

Overcoming hurdles in a regulated setting

Driven by the rapid increase of biologic therapies in development, advanced techniques in quantitative analysis of protein therapeutics and biomarkers by LC-MS now allow unprecedented levels of sensitivity, selectivity, precision, and accuracy. Two such approaches are high resolution accurate mass spectrometry (HRMS) and hybrid immunoaffinity liquid chromatography-mass spectrometry (IA-LC-MS).

Q2 Solutions is a pioneer in helping drive advances in the bioanalysis of protein-based drugs and biomarkers. Download this insight brief to learn how we continue to incorporate advanced techniques and technologies, such as HRMS, IA-LC-MS, and low-flow chromatography and ionization, into our methodologies to optimize our customers' drug development outcomes.

Barry Jones, Ph.D., Associate Director, LCMS Biologics and Biomarkers

Complete the form below to access this insight brief